Moderna Receives FDA Approval for RSV Vaccine Based on Penn Technology
RSV is a highly contagious seasonal respiratory virus and a leading cause of lower respiratory tract infections and pneumonia.
Penn’s CAR-T Treatment Shrank Brain Tumors in Patients in Clinical Trial
In a new early-stage clinical trial, a Penn-invented CAR-T treatment shrank brain tumors in seven patients with glioblastoma.
Capstan raises $175M Series B
Proceeds from the financing will be used to advance Capstan's lead in vivo chimeric antigen receptor T cell (CAR-T) candidate, CPTX2309, to early clinical proof-of-concept in autoimmune disorders.
iEcure Gains FDA approval to Conduct FirstGene Therapy Treatment
Utilizing ARCUS, a gene editing tool developed by Precision BioSciences, the therapy aims to provide a lifelong fix for this disease, potentially benefiting thousands of individuals in the US alone.
Penn Researchers Discover New Technique to Form Human Artificial Chromosomes
Researchers at Penn led by Ben Black, PhD, the Eldridge Reeves Johnson Foundation Professor of Biochemistry and Biophysics, have found a new way to create synthetic chromosomes.
Philly Nonprofit Awarded $48 Million to Apply AI in Search for New Uses for Approved Drugs
AI based on specific algorithms will scan tens of thousands of approved medications and rare diseases to find potential matches.
Penn Leaders Featured in the Philadelphia Business Journal’s Power 100 List
PCI congratulates these Penn leaders for their inclusion in the Philadelphia Business Journal's list of "100 business leaders set to shape Philadelphia in 2024."
AInSights Uses AI for Real-time Image Analysis
Penn Medicine's AInSights is a cloud-based machine learning platform accessible by clinicians for real-time image analysis supporting multiple machine learning algorithms.
The Future Applications of Penn Medicine’s mRNA Technology
Weissman has partnered in building 18 mRNA-capable Good Manufacturing Practice (GMP) sites to date across the world.
Penn health system profits support medical research and teaching over past decade
Penn was highlighted in the Philadelphia Inquirer for investing $2 billion in profits from its health system into medical research and physician support over the past decade.